HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qingyi Wei Selected Research

Codon (Codons)

8/2012Combined p53-related genetic variants together with HPV infection increase oral cancer risk.
1/2012Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.
1/2012Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy.
1/2012Association of combined p73 and p53 genetic variants with tumor HPV16-positive oropharyngeal cancer.
9/2011Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck.
12/2010A novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neck.
11/2010Glutathione-S-transferase polymorphisms and complications of microvascular head and neck reconstruction.
5/2010Association of p53 codon 72 polymorphism with risk of second primary malignancy in patients with squamous cell carcinoma of the head and neck.
2/2010Definition of a functional single nucleotide polymorphism in the cell migration inhibitory gene MIIP that affects the risk of breast cancer.
10/2009An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qingyi Wei Research Topics

Disease

197Neoplasms (Cancer)
01/2022 - 02/2002
49Lung Neoplasms (Lung Cancer)
01/2022 - 02/2002
49Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 07/2002
46Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2002
44Carcinogenesis
10/2021 - 10/2003
36Melanoma (Melanoma, Malignant)
03/2021 - 12/2003
24Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2020 - 08/2005
20Oropharyngeal Neoplasms
01/2022 - 07/2005
19Breast Neoplasms (Breast Cancer)
01/2020 - 09/2004
15Stomach Neoplasms (Stomach Cancer)
01/2019 - 03/2004
12Radiation Pneumonitis
01/2018 - 07/2009
12Genetic Predisposition to Disease (Genetic Predisposition)
06/2015 - 05/2002
10Head and Neck Neoplasms (Head and Neck Cancer)
04/2013 - 01/2004
8Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 07/2005
8Inflammation (Inflammations)
11/2019 - 02/2008
8Glioma (Gliomas)
10/2012 - 04/2004
7Genomic Instability
06/2016 - 11/2006
6Adenocarcinoma
06/2020 - 03/2006
6Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2015 - 01/2009
6Infections
07/2013 - 11/2004
5Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 01/2018
5Ovarian Epithelial Carcinoma
01/2020 - 07/2005
5Carcinoma (Carcinomatosis)
10/2015 - 10/2007
5Xeroderma Pigmentosum (Kaposi's Disease)
01/2012 - 05/2007
5Urinary Bladder Neoplasms (Bladder Cancer)
06/2008 - 06/2002
4Mouth Neoplasms (Oral Cancer)
01/2022 - 09/2002
4Adenocarcinoma of Lung
01/2020 - 08/2006
4Esophageal Squamous Cell Carcinoma
11/2018 - 07/2012
4Prostatic Neoplasms (Prostate Cancer)
01/2018 - 06/2009
4Thyroid Neoplasms (Thyroid Cancer)
05/2013 - 07/2004
4Neoplasm Metastasis (Metastasis)
05/2013 - 08/2005
3Chromosome Aberrations (Chromosome Abnormalities)
12/2007 - 07/2004
2Ataxia Telangiectasia (Louis Bar Syndrome)
11/2022 - 05/2008

Drug/Important Bio-Agent (IBA)

44Proteins (Proteins, Gene)FDA Link
01/2020 - 12/2003
36Biomarkers (Surrogate Marker)IBA
03/2021 - 02/2002
30DNA (Deoxyribonucleic Acid)IBA
01/2021 - 10/2003
28MicroRNAs (MicroRNA)IBA
04/2020 - 10/2010
22Messenger RNA (mRNA)IBA
01/2022 - 07/2005
21Biological ProductsIBA
11/2020 - 10/2004
18PlatinumIBA
01/2020 - 05/2011
18Codon (Codons)IBA
08/2012 - 09/2002
17CarcinogensIBA
04/2016 - 01/2002
16ORALIT (ORS)IBA
01/2021 - 10/2003
163' Untranslated Regions (3' UTR)IBA
12/2019 - 09/2005
13MutagensIBA
04/2016 - 12/2005
13Folic Acid (Vitamin M)FDA LinkGeneric
01/2013 - 10/2003
10Epoxy Compounds (Epoxides)IBA
01/2012 - 02/2002
10Benzo(a)pyreneIBA
01/2012 - 02/2002
9DNA AdductsIBA
11/2018 - 09/2004
9SmokeIBA
01/2017 - 10/2003
8Oncogene Proteins (Oncogene Protein)IBA
12/2019 - 04/2008
8EnzymesIBA
06/2016 - 05/2007
87,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxideIBA
01/2012 - 10/2003
8arginylarginine (Arg-Arg)IBA
01/2012 - 09/2002
6CytokinesIBA
11/2019 - 11/2004
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 01/2013
6AntibodiesIBA
12/2017 - 07/2003
6Thymidylate SynthaseIBA
09/2015 - 12/2004
5Telomerase (Telomerase Reverse Transcriptase)IBA
03/2017 - 10/2003
51,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
01/2017 - 09/2007
5Tumor Suppressor Protein p14ARF (p14ARF)IBA
01/2014 - 03/2011
5CytosineIBA
01/2012 - 09/2002
5Glutathione Transferase (Glutathione S-Transferase)IBA
11/2010 - 04/2004
5Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2007 - 01/2004
4NucleotidesIBA
01/2022 - 05/2006
4Vitamin DFDA LinkGeneric
01/2020 - 02/2007
4Estrogen ReceptorsIBA
04/2015 - 04/2006
4Transforming Growth Factors (Transforming Growth Factor)IBA
01/2013 - 07/2009
4arginylprolineIBA
08/2012 - 09/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2012 - 06/2009
4Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
04/2012 - 02/2005
4AdenineFDA LinkGeneric
01/2012 - 04/2007
4GuanineIBA
01/2012 - 04/2007
4ADP Ribose Transferases (ADP Ribosyltransferase)IBA
11/2011 - 02/2005
4Estrogens (Estrogen)FDA Link
04/2011 - 06/2005
4prolyl-proline (Pro-Pro)IBA
11/2008 - 09/2002
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 08/2014
3Genetic Markers (Genetic Marker)IBA
12/2021 - 02/2010
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2020 - 01/2008
3Protein Kinases (Protein Kinase)IBA
01/2019 - 05/2008
3AntigensIBA
01/2018 - 07/2015
3Platelet-Derived Growth FactorIBA
01/2018 - 05/2013
3Metalloproteases (Metalloproteinases)IBA
01/2018 - 01/2011
3C-Reactive ProteinIBA
01/2017 - 04/2015
3Cisplatin (Platino)FDA LinkGeneric
06/2013 - 01/2012
3Caspase 3 (Caspase-3)IBA
04/2013 - 01/2008
3ThymineIBA
01/2012 - 04/2007
3A-Form DNA (A-DNA)IBA
01/2012 - 09/2005
3Caspase 8 (Caspase-8)IBA
01/2012 - 12/2008
3Carrier Proteins (Binding Protein)IBA
05/2011 - 07/2006
3Calcitriol Receptors (Calcitriol Receptor)IBA
06/2009 - 03/2005
35' Untranslated Regions (5' UTR)IBA
01/2009 - 05/2007
3Progesterone Receptors (Progesterone Receptor)IBA
05/2007 - 06/2005
3Fas Ligand Protein (Fas Ligand)IBA
09/2006 - 04/2006
2Phosphotransferases (Kinase)IBA
11/2022 - 01/2019

Therapy/Procedure

23Radiotherapy
12/2019 - 02/2003
22Drug Therapy (Chemotherapy)
01/2020 - 07/2002
18Therapeutics
01/2019 - 06/2002
7Chemoradiotherapy
11/2015 - 08/2010
3Immunotherapy
04/2020 - 01/2019